<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Clinical Endocrinology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Clinical Endocrinology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Clinical+Endocrinology&t=Clinical+Endocrinology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:08:50 +0100</lastBuildDate>
        <item>
            <title>Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5644251&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04353.x</link>
            <description>ConclusionBGC occurs in 73.8% of patients with IH and correlates with the duration of hypocalcaemia, choroid plexus calcification, seizures and cataract. Progression of BGC is related to the calcium‐phosphorus ratio during follow up. This brings forth the importance of adequate phosphorus control in the management of hypoparathyroidism.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644251</comments>
            <pubDate>Tue, 31 Jan 2012 19:54:07 +0100</pubDate>
            <guid isPermaLink="false">5644251</guid>        </item>
        <item>
            <title>Adipokine profile in glucocorticoid‐treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy</title>
            <link>http://www.medworm.com/index.php?rid=5627124&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04348.x</link>
            <description>ConclusionGIL is associated with a different adipokine profile both before and after glucocorticoid therapy. Serum leptin level prior to glucocorticoid therapy is highly predictive of GIL occurrence.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627124</comments>
            <pubDate>Wed, 25 Jan 2012 20:35:25 +0100</pubDate>
            <guid isPermaLink="false">5627124</guid>        </item>
        <item>
            <title>Expression of the proliferation marker Ki‐67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas</title>
            <link>http://www.medworm.com/index.php?rid=5607243&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04343.x</link>
            <description>Conclusions:  In patients with DTC, Ki‐67 expression associates with tumour staging and clinical outcome.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5607243</comments>
            <pubDate>Thu, 19 Jan 2012 23:24:06 +0100</pubDate>
            <guid isPermaLink="false">5607243</guid>        </item>
        <item>
            <title>Carotid intima‐media thickness is increased in Turner syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and oestrogen treatment</title>
            <link>http://www.medworm.com/index.php?rid=5580236&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04337.x</link>
            <description>Conclusion:  Carotid IMT was abnormal in TS and negatively influenced by age, metabolic biomarkers, blood pressure and short duration of oestrogen treatment. Attention to common cardiovascular and endocrine risk markers over more than two years appeared to influence IMT beneficially.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580236</comments>
            <pubDate>Fri, 13 Jan 2012 06:48:06 +0100</pubDate>
            <guid isPermaLink="false">5580236</guid>        </item>
        <item>
            <title>Congenital hyperinsulinism: marked clinical heterogeneity in siblings with identical mutations in the ABCC8 gene</title>
            <link>http://www.medworm.com/index.php?rid=5568750&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04203.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568750</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:48 +0100</pubDate>
            <guid isPermaLink="false">5568750</guid>        </item>
        <item>
            <title>Development of hypothyroidism during long‐term follow‐up of patients with toxic nodular goitre after radioiodine therapy</title>
            <link>http://www.medworm.com/index.php?rid=5568749&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04204.x</link>
            <description>Conclusions  Radioiodine treatment with a calculated dose regimen is a highly effective treatment option in patients with toxic goitre with an overall success rate of 98%. However, radioiodine treatment with an intended thyroid dose of 150 Gy leads to a high incidence of hypothyroidism on long‐term follow‐up. This finding supports the suggestion that in future intended thyroid doses could be lowered in patients treated with a calculated dose regimen for toxic nodular goitre. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568749</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:45 +0100</pubDate>
            <guid isPermaLink="false">5568749</guid>        </item>
        <item>
            <title>Changes in TNM stage, reoperation and 131‐I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5568748&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04199.x</link>
            <description>Conclusions  The evaluation of thyroid nodules using the newer diagnostic methods was useful in identifying DTC early. Consequently, the reoperation and thyroid remnant ablation rates were reduced. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568748</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:43 +0100</pubDate>
            <guid isPermaLink="false">5568748</guid>        </item>
        <item>
            <title>Acute testosterone deprivation reduces insulin sensitivity in men</title>
            <link>http://www.medworm.com/index.php?rid=5568747&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04189.x</link>
            <description>Conclusions  Acute testosterone withdrawal reduces insulin sensitivity in men independent of changes in body weight, whereas estradiol withdrawal has no effect. Testosterone appears to maintain insulin sensitivity in normal men. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568747</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:41 +0100</pubDate>
            <guid isPermaLink="false">5568747</guid>        </item>
        <item>
            <title>Non steroidal anti‐inflammatory drug use and levels of oestrogens and androgens in men</title>
            <link>http://www.medworm.com/index.php?rid=5568746&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04188.x</link>
            <description>Conclusions  While overall these data do not provide strong support for an association between NSAID use and hormone levels in men, prescription NSAIDs may decrease levels of certain oestrogens and androgens in obese and inactive men. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568746</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:39 +0100</pubDate>
            <guid isPermaLink="false">5568746</guid>        </item>
        <item>
            <title>Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=5568745&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04180.x</link>
            <description>Conclusions  In 13 newly described pregnancies along with systematic review of an additional 34 cases indicate that pregnancy in treated acromegalic women can proceed without significant complications or teratogenicity. Medical treatment during pregnancy with DA or SA appears to be associated with altered neonatal weight. Nevertheless, gestation may have a beneficial impact on acromegaly control both during and following pregnancy. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568745</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:38 +0100</pubDate>
            <guid isPermaLink="false">5568745</guid>        </item>
        <item>
            <title>Plasma corticotrophin response to desmopressin in patients with Cushing’s disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours</title>
            <link>http://www.medworm.com/index.php?rid=5568744&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04179.x</link>
            <description>Conclusions  We concluded that V2R was expressed on corticotrophinomas and that the level of its expression correlated well with the ACTH response to desmopressin in CD patients, although abundant expression of V1R and V3R was also found in almost all corticotroph tumours. Further studies are needed to elucidate the role of these receptors in the pathogenesis of CD. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568744</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:36 +0100</pubDate>
            <guid isPermaLink="false">5568744</guid>        </item>
        <item>
            <title>Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism</title>
            <link>http://www.medworm.com/index.php?rid=5568743&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04174.x</link>
            <description>Conclusion  The current average HCeq dose of approximately 20 mg per day is not associated with an adverse metabolic profile, as compared with ACTHsuff patients with hypopituitarism. GC replacement in ACTHins women is independently associated with reduced BMD and higher prevalence of osteopenia. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568743</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:34 +0100</pubDate>
            <guid isPermaLink="false">5568743</guid>        </item>
        <item>
            <title>Acute evaluation of pituitary function in patients with Crimean‐Congo haemorrhagic fever</title>
            <link>http://www.medworm.com/index.php?rid=5568742&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04173.x</link>
            <description>Conclusion  To our knowledge, this is the first study reporting the effect of CCHF on pituitary function. We found that cortisol insufficiency may occur in patients diagnosed with CCHF; however, studies including a larger number of patients are required to make a definite conclusion on this issue. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568742</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:32 +0100</pubDate>
            <guid isPermaLink="false">5568742</guid>        </item>
        <item>
            <title>Plasma C‐type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease</title>
            <link>http://www.medworm.com/index.php?rid=5568741&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04187.x</link>
            <description>Conclusions  Plasma CNP peptides are higher in children with hyperthyroidism than in those with hypothyroidism at diagnosis and, in hyperthyroid children, change concordantly with TH and HV during treatment. Differential responses of CNP in the two groups suggest CNP production is dependent on growth plate activity and not a direct effect of TH on CNP gene expression. Our findings suggest novel mechanisms underlying changes in skeletal response during treatment in children with acquired thyroid disease. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568741</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:29 +0100</pubDate>
            <guid isPermaLink="false">5568741</guid>        </item>
        <item>
            <title>A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations</title>
            <link>http://www.medworm.com/index.php?rid=5568740&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04159.x</link>
            <description>Conclusions/interpretation  Defects in insulin secretion and action interact with body composition and gender to influence postchallenge glucose concentrations. There is considerable heterogeneity of insulin secretion and action for a given fasting glucose likely because of patient subsets with isolated IFG and normal glucose tolerance. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568740</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:25 +0100</pubDate>
            <guid isPermaLink="false">5568740</guid>        </item>
        <item>
            <title>Association of serum retinol‐binding protein 4 with insulin resistance and metabolic parameters during olanzapine therapy</title>
            <link>http://www.medworm.com/index.php?rid=5568739&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04150.x</link>
            <description>Conclusions  Our results suggest that RBP4 levels might be associated with at least some olanzapine‐induced metabolic abnormalities and cardiovascular disease risk factors. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568739</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:24 +0100</pubDate>
            <guid isPermaLink="false">5568739</guid>        </item>
        <item>
            <title>Association between 25‐OH vitamin D and insulin is independent of lipoatrophy in HIV</title>
            <link>http://www.medworm.com/index.php?rid=5568738&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04149.x</link>
            <description>Conclusions  Lower 25(OH)D is associated with higher serum insulin but not lipoatrophy or hypoadiponectinemia in HIV‐infected patients. The association between VDD and insulin resistance is likely to be mediated by independent mechanisms. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568738</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:22 +0100</pubDate>
            <guid isPermaLink="false">5568738</guid>        </item>
        <item>
            <title>The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5568737&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04197.x</link>
            <description>Conclusions  Asymptomatic pHPT is associated with neuropsychological symptoms that improve after parathyroidectomy. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568737</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:20 +0100</pubDate>
            <guid isPermaLink="false">5568737</guid>        </item>
        <item>
            <title>Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?</title>
            <link>http://www.medworm.com/index.php?rid=5568736&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04233.x</link>
            <description>SummaryAndrogen administration can cause prostate cancer progression, and androgen deprivation therapy is a commonly used therapeutic modality in the treatment of prostate cancer. In trying to answer the posed clinical question, this article reviews the risks and benefits of testosterone replacement therapy in this setting and the published data from clinical series. Recommendations are made based on the available evidence. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568736</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:15 +0100</pubDate>
            <guid isPermaLink="false">5568736</guid>        </item>
        <item>
            <title>Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk1</title>
            <link>http://www.medworm.com/index.php?rid=5568735&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04216.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568735</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:13 +0100</pubDate>
            <guid isPermaLink="false">5568735</guid>        </item>
        <item>
            <title>The use of neuroimaging for assessing disorders of pituitary development</title>
            <link>http://www.medworm.com/index.php?rid=5568734&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04238.x</link>
            <description>SummaryMagnetic resonance imaging (MRI) is the radiological examination method of choice for evaluating hypothalamo‐pituitary‐related endocrine disease and is considered essential in the assessment of patients with suspected hypothalamo‐pituitary pathology. Physicians involved in the care of such patients have, in MRI, a valuable tool that can aid them in determining the pathogenesis of their patients’ underlying pituitary conditions. Indeed, the use of MRI has led to an enormous increase in our knowledge of pituitary morphology, improving, in particular, the differential diagnosis of hypopituitarism. Specifically, MRI allows detailed and precise anatomical study of the pituitary gland by differentiating between the anterior and posterior pituitary lobes. MRI recognition of pituita...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568734</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:12 +0100</pubDate>
            <guid isPermaLink="false">5568734</guid>        </item>
        <item>
            <title>Rathke’s cleft cysts</title>
            <link>http://www.medworm.com/index.php?rid=5568733&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04235.x</link>
            <description>SummaryRathke’s cleft cysts (RCCs) are benign, sellar and/or suprasellar lesions originating from the remnants of Rathke’s pouch. Although a common finding in routine autopsies (12–33% of normal pituitary glands), symptomatic cases are rare and comprise 5–15% of all surgically resected sellar lesions. Small, asymptomatic RCC do not require surgical intervention, and their natural history is not clear. In series of nonoperated presumed RCCs, 26–94% did not progress during follow‐up periods up to 9 years. In symptomatic ones, surgery is indicated, aiming to drain the cyst content and safely remove as much of the capsule as possible. Following surgical intervention, headaches and visual field defects improve or resolve in a significant number of patients (40–100% and 33–100%...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568733</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:10 +0100</pubDate>
            <guid isPermaLink="false">5568733</guid>        </item>
        <item>
            <title>The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population</title>
            <link>http://www.medworm.com/index.php?rid=5568730&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04329.x</link>
            <description>Conclusions:  These results suggest that apoB/A1 ratio is independently associated with MetS and that an apoB/A1 ratio greater than 0.65 in men and 0.62 in women is a marker of MetS independent from conventional risk factors© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568730</comments>
            <pubDate>Sat, 07 Jan 2012 02:18:05 +0100</pubDate>
            <guid isPermaLink="false">5568730</guid>        </item>
        <item>
            <title>Timing of Gonadectomy In Adult Women with Compete Androgen Insensitivity Syndrome (CAIS): Patient Preferences and Clinical Evidence</title>
            <link>http://www.medworm.com/index.php?rid=5568732&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04330.x</link>
            <description>Conclusions:  Perceived benefits for retaining gonads in women with CAIS are prompting more women to keep their gonads in situ. An accurate estimate for adult malignancy risk is unavailable and the risks currently quoted may be falsely reassuring.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568732</comments>
            <pubDate>Mon, 02 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5568732</guid>        </item>
        <item>
            <title>Association between plasma 25‐OH vitamin D and testosterone levels in men</title>
            <link>http://www.medworm.com/index.php?rid=5568731&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2012.04332.x</link>
            <description>Conclusion:  This study supports previously reported positive associations between vitamin D and testosterone although we did not observe parallel seasonal variation patterns. Possible causality and direction of the vitamin D‐testosterone association deserve further scientific investigation.© 2012 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568731</comments>
            <pubDate>Mon, 02 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5568731</guid>        </item>
        <item>
            <title>Body fat distribution in relation to smoking and exogenous hormones in British women</title>
            <link>http://www.medworm.com/index.php?rid=5552896&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04331.x</link>
            <description>Conclusion:  Although exogenous hormones use was related to a more favourable fat distribution in women, smoking was associated with greater abdominal fat accumulation.© 2011 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552896</comments>
            <pubDate>Sat, 31 Dec 2011 13:48:41 +0100</pubDate>
            <guid isPermaLink="false">5552896</guid>        </item>
        <item>
            <title>Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins</title>
            <link>http://www.medworm.com/index.php?rid=5538878&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04321.x</link>
            <description>Conclusion:  Our findings do not support an association between low 25OHD levels and statin‐induced myalgia or CK‐elevation.© 2011 Blackwell Publishing Ltd (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5538878</comments>
            <pubDate>Sun, 25 Dec 2011 11:18:08 +0100</pubDate>
            <guid isPermaLink="false">5538878</guid>        </item>
        <item>
            <title>A Japanese Family with Familial Nonautoimmune Hyperthyroidism with A Novel Mutation (Asn406Ser) in Extracellular Domain of Thyrotropin Receptor</title>
            <link>http://www.medworm.com/index.php?rid=5516352&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04324.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516352</comments>
            <pubDate>Mon, 19 Dec 2011 13:24:07 +0100</pubDate>
            <guid isPermaLink="false">5516352</guid>        </item>
        <item>
            <title>Twin studies as a model for exploring the aetiology of autoimmune thyroid disease</title>
            <link>http://www.medworm.com/index.php?rid=5496638&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04318.x</link>
            <description>SummaryTwins are an important resource for evaluating the relative contribution of genetic and environmental factors in determining a phenotype. During the last decades a number of twin studies have investigated the aetiology of several phenotypes related to thyroid autoimmunity. Taken together, these studies have provided valid and unbiased information regarding the influence of genetic and environmental factors in the aetiology of autoimmune thyroid disease (AITD). The comparison of concordance rates between monozygotic and dizygotic twins provides irrefutable evidence of a genetic component, and biometric twin modelling shows that approximately 75% of the total phenotypic variance in AITD is due to genetic effects. On the other hand, the lack of complete concordance in monozygotic twin ...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5496638</comments>
            <pubDate>Tue, 13 Dec 2011 17:18:06 +0100</pubDate>
            <guid isPermaLink="false">5496638</guid>        </item>
        <item>
            <title>Molecular analysis of the PAX8 gene in a sample of Mexican patients with primary congenital hypothyroidism: identification of the recurrent p.Arg31His mutation</title>
            <link>http://www.medworm.com/index.php?rid=5480752&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04153.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480752</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:56 +0100</pubDate>
            <guid isPermaLink="false">5480752</guid>        </item>
        <item>
            <title>Decreased serum vascular endothelial growth factor‐D levels in metastatic patients with differentiated thyroid carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5480751&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04183.x</link>
            <description>Conclusions  Our data demonstrate that the VEGF‐D serum levels are reduced in patients with metastases of differentiated thyroid cancer, regardless of the degree of metastatic spread. It is possible that some other molecule produced by the tumoral tissue could affect the VEGF‐D physiologically produced of from different tissues, thus conducting to a decrease in the VEGF‐D found in blood of patients with evidence of metastatic differentiated thyroid cancer. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480751</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:53 +0100</pubDate>
            <guid isPermaLink="false">5480751</guid>        </item>
        <item>
            <title>Assessment of gonadotrophin suppression in girls treated with GnRH analogue for central precocious puberty; validity of single luteinizing hormone measurement after leuprolide acetate injection</title>
            <link>http://www.medworm.com/index.php?rid=5480750&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04185.x</link>
            <description>Conclusion  Single LH determination 90 min after GnRHa administration using a cut‐off level of 2·5 mIU/ml reflects pubertal suppression with a high sensitivity and specificity. However, this test may fail to show pubertal suppression in some cases. Those patients who appear to be inadequately suppressed should be reassessed using standard iv GnRH stimulation test for optimal dose adjustment. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480750</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:48 +0100</pubDate>
            <guid isPermaLink="false">5480750</guid>        </item>
        <item>
            <title>Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5480749&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04171.x</link>
            <description>Conclusion  Visfatin may be a candidate to play a role in the pathogenesis of endothelial dysfunction in PCOS, independently of additional risk factors. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480749</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:46 +0100</pubDate>
            <guid isPermaLink="false">5480749</guid>        </item>
        <item>
            <title>Sex hormone–binding globulin at the crossroad of body composition, somatotropic axis and insulin/glucose homeostasis in young healthy men</title>
            <link>http://www.medworm.com/index.php?rid=5480748&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04155.x</link>
            <description>Conclusions  In conclusion, we found that fat mass, insulin and IGF‐1 levels are important negative determinants of SHBG levels in young healthy men. The association with fat mass could be mediated by the effects of adiponectin and/or leptin on SHBG synthesis. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480748</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:44 +0100</pubDate>
            <guid isPermaLink="false">5480748</guid>        </item>
        <item>
            <title>The impact of the site of origin and rate of tumour growth on clinical outcome in children with craniopharyngiomas</title>
            <link>http://www.medworm.com/index.php?rid=5480747&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04172.x</link>
            <description>Conclusions  Substantial differences in the outcome of childhood CP with different tumour growth patterns and locations were found, which suggested that diverse therapeutic considerations, especially endocrinological substitution, might be emphasized. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480747</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:43 +0100</pubDate>
            <guid isPermaLink="false">5480747</guid>        </item>
        <item>
            <title>Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5480746&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04163.x</link>
            <description>Conclusions  Densely granulated adenomas were highly responsive to somatostatin analogues in contrast to SG adenomas. The transitional group behaved clinically more like DG adenomas. However, based on E‐cadherin, a marker of dedifferentiation, the transitional group seemed to be a true intermediate. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480746</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:41 +0100</pubDate>
            <guid isPermaLink="false">5480746</guid>        </item>
        <item>
            <title>Effects on metabolic variables after 12‐month treatment with a new once‐a‐week sustained‐release recombinant growth hormone (GH: LB03002) in patients with GH deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5480745&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04146.x</link>
            <description>Conclusion  Substitution with LB03002 showed statistically significant reduction in FM, which reduces leptin levels and increases ghrelin levels but does not seem to influence glucose and lipid metabolism. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480745</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:39 +0100</pubDate>
            <guid isPermaLink="false">5480745</guid>        </item>
        <item>
            <title>Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader–Willi syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5480744&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04161.x</link>
            <description>Conclusion  PWS patients display heterogeneity of hypogonadism: (i) hypogonadotropic hypogonadism of central origin for LH and/or FSH; (ii) early primary testicular dysfunction (Sertoli cells damage); and (iii) a combined hypogonadism (testicular origin for FSH‐inhibin B axis and central origin for LH‐T axis). (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480744</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:36 +0100</pubDate>
            <guid isPermaLink="false">5480744</guid>        </item>
        <item>
            <title>The relationship between fat depot‐specific preadipocyte differentiation and metabolic syndrome in obese women</title>
            <link>http://www.medworm.com/index.php?rid=5480743&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04141.x</link>
            <description>Conclusions  This study identified that SC‐preadipocyte differentiation is associated with metabolic syndrome independent of obesity, whereas OM‐preadipocyte differentiation is not. These findings suggest that, in the setting of obesity, an enhanced adipogenic capacity of SC depots could be protective for metabolic syndrome. Our data underscores an interaction between adipose tissue homoeostasis and metabolic disorder. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480743</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:33 +0100</pubDate>
            <guid isPermaLink="false">5480743</guid>        </item>
        <item>
            <title>Coronary artery disease is associated with higher epicardial Retinol‐binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue</title>
            <link>http://www.medworm.com/index.php?rid=5480742&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04140.x</link>
            <description>Conclusion  Retinol‐binding protein 4 levels behave differently in EAT and SAT with respect to CAD. However, both adipose tissues have lower GLUT4 levels in patients with CAD. These findings suggest a differential regulation of RBP4 production in EAT and SAT that may be influenced by local factors. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480742</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:31 +0100</pubDate>
            <guid isPermaLink="false">5480742</guid>        </item>
        <item>
            <title>Identification of the first germline HRPT2 whole‐gene deletion in a patient with primary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5480741&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04184.x</link>
            <description>Conclusions  We report the first large germline deletion of the HRPT2 gene, which was not detectable by conventional PCR‐based sequencing methods. This finding emphasizes that qPCR should be implemented in HRPT2 molecular analysis, which may improve genetic assessment and clinical management of patients with FIHP and HPT‐JT. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480741</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:26 +0100</pubDate>
            <guid isPermaLink="false">5480741</guid>        </item>
        <item>
            <title>100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes</title>
            <link>http://www.medworm.com/index.php?rid=5480740&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04177.x</link>
            <description>Conclusions  Patients with PA should have CT scanning and AVS. Aldo/Cort A:U &amp;gt;2·0 is the most accurate of previously published ratios in predicting unilateral disease. When patients were carefully selected for surgery, 97% had cure or improvement in blood pressure control. Further confirmatory work is required on a novel ratio which was even more predictive in our series. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480740</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:25 +0100</pubDate>
            <guid isPermaLink="false">5480740</guid>        </item>
        <item>
            <title>What is the best long‐term management strategy for patients with primary adrenal insufficiency?</title>
            <link>http://www.medworm.com/index.php?rid=5480739&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04103.x</link>
            <description>This article provides answers to the important daily clinical questions, such as correct dose finding, dose adaptation in special situations, e g, pregnancy, improvement of quality of life and measures for protection from adrenal crisis. Other important aspects discussed are side effects of glucocortiocid replacement therapy and interactions with other drugs. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480739</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:23 +0100</pubDate>
            <guid isPermaLink="false">5480739</guid>        </item>
        <item>
            <title>Metabolic syndrome: is the preadipocyte to blame?*</title>
            <link>http://www.medworm.com/index.php?rid=5480738&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04176.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480738</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:21 +0100</pubDate>
            <guid isPermaLink="false">5480738</guid>        </item>
        <item>
            <title>Subclinical Cushing’s syndrome: definition and management</title>
            <link>http://www.medworm.com/index.php?rid=5480737&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04253.x</link>
            <description>SummarySubclinical Cushing’s syndrome is an ill‐defined endocrine disorder that may be observed in patients bearing an incidentally found adrenal adenoma. The concept of subclinical Cushing’s syndrome stands on the presence of ACTH‐independent cortisol secretion by an adrenal adenoma, that is not fully restrained by pituitary feed‐back. A hypercortisolemic state of usually minimal intensity may ensue and eventually cause harm to the patients in terms of metabolic and vascular diseases, and bone fractures. However, the natural history of subclinical Cushing’s syndrome remains largely unknown. The present review illustrates the currently used methods to ascertain the presence of subclinical Cushing’s syndrome and the surrounding controversy. The management of subclinical Cushin...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480737</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:19 +0100</pubDate>
            <guid isPermaLink="false">5480737</guid>        </item>
        <item>
            <title>Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia</title>
            <link>http://www.medworm.com/index.php?rid=5480736&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04234.x</link>
            <description>SummaryProteins secreted from adipocytes – so‐called adipokines – influence metabolic and vascular function. Recent data suggest that various adipokines are dysregulated in gestational diabetes mellitus (GDM) and pre‐eclampsia (PE) and might be of pathophysiological and prognostic significance in these complications of pregnancy. This review gives an overview on the regulation and pathophysiology of leptin and adiponectin in GDM and PE. Furthermore, data on novel adipokines including resistin, visfatin, retinol‐binding protein 4 and vaspin are summarized. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480736</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:17 +0100</pubDate>
            <guid isPermaLink="false">5480736</guid>        </item>
        <item>
            <title>Clinical Endocrinology in 2012: recent changes and future opportunities</title>
            <link>http://www.medworm.com/index.php?rid=5480735&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04281.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480735</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:16 +0100</pubDate>
            <guid isPermaLink="false">5480735</guid>        </item>
        <item>
            <title>Metabolite profiling as a future tool in the prediction of type 2 diabetes mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5480730&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04298.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480730</comments>
            <pubDate>Wed, 07 Dec 2011 22:06:07 +0100</pubDate>
            <guid isPermaLink="false">5480730</guid>        </item>
        <item>
            <title>Birth weight is inversely associated with blood pressure and serum aldosterone and cortisol levels in children.</title>
            <link>http://www.medworm.com/index.php?rid=5480732&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04308.x</link>
            <description>Conclusions:  The results of this study demonstrate an inverse association between birth weight and blood pressure and serum aldosterone and cortisol levels. This association is independent of BMI and Tanner, suggesting foetal programming of the hypothalamic‐ pituitary‐ adrenal axis. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480732</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480732</guid>        </item>
        <item>
            <title>Adolescents with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency have vascular dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=5480731&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04309.x</link>
            <description>Conclusions:  Subjects with CAH have evidence of vascular dysfunction by adolescence. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480731</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480731</guid>        </item>
        <item>
            <title>Thyroid status two decades after salt iodisation: Country‐wide data in school children from India</title>
            <link>http://www.medworm.com/index.php?rid=5480733&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04307.x</link>
            <description>Conclusions:   EndemicGoitre in school children persisted nationwide, despite more than two decades of USI program. Thyroid autoimmunity only partially explainsthe increase in goitre prevalence. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480733</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480733</guid>        </item>
        <item>
            <title>Diferential Effect of Oral Dehydroepiandrosterone‐Sulphate on Metabolic Syndrome Features in Pre‐ and Postmenopausal Obese Women</title>
            <link>http://www.medworm.com/index.php?rid=5480734&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04306.x</link>
            <description>Conclusions:  An oral dose of DHEA‐S is useful for weight loss. In obese postmenopausal women the hormone significantly improves plasma biochemical levels and anthropometric characteristics, leading to a better metabolic profile, which highlights the usefulness of this therapy against Metabolic‐Syndrome in this group of women. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5480734</comments>
            <pubDate>Fri, 02 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5480734</guid>        </item>
        <item>
            <title>Growth Hormone Insensitivity Syndrome caused by a heterozygous GHR mutation: phenotypic variability due to moderation by nonsense‐mediated decay</title>
            <link>http://www.medworm.com/index.php?rid=5446781&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04304.x</link>
            <description>Conclusions:  GHIS in this patient is due to a heterozygous nonsense mutation in GHR. Our study is the first to demonstrate that nonsense‐mediated decay is involved in the phenotypic variability of GHIS caused by GHR mutations. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446781</comments>
            <pubDate>Sat, 26 Nov 2011 06:36:06 +0100</pubDate>
            <guid isPermaLink="false">5446781</guid>        </item>
        <item>
            <title>Referees</title>
            <link>http://www.medworm.com/index.php?rid=5428166&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04254.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428166</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:16 +0100</pubDate>
            <guid isPermaLink="false">5428166</guid>        </item>
        <item>
            <title>Dilated cardiomyopathy: a possibly underestimated presentation of Cushing’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5428165&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04091.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428165</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:13 +0100</pubDate>
            <guid isPermaLink="false">5428165</guid>        </item>
        <item>
            <title>Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5428164&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04120.x</link>
            <description>Conclusions  The mode of dialyzer modulates the blood levels of myostatin. Higher myostatin is associated with lower muscle function. The use of myostatin assay in various clinical settings merits further investigation. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428164</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:11 +0100</pubDate>
            <guid isPermaLink="false">5428164</guid>        </item>
        <item>
            <title>Daily urine iodine excretion while consuming a low‐iodine diet in preparation for radioactive iodine therapy in a high iodine intake area</title>
            <link>http://www.medworm.com/index.php?rid=5428163&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04157.x</link>
            <description>Conclusions  One week of a strict LID is enough to decrease the level of urine iodine excretion in preparation for RAIT even in high iodine intake areas. These results provide essential data for future outcome studies regarding LID preparation for RAIT. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428163</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:09 +0100</pubDate>
            <guid isPermaLink="false">5428163</guid>        </item>
        <item>
            <title>The BRAFV600E mutation is associated with malignant ultrasonographic features in thyroid nodules</title>
            <link>http://www.medworm.com/index.php?rid=5428162&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04154.x</link>
            <description>Conclusion  The BRAFV600E mutation is significantly associated with malignant US features, such as solid composition, marked hypoechogenicity, irregular margin, taller‐than‐wide shape and the presence of microcalcifications. The application of BRAFV600E mutation analysis in US‐guided FNAB can improve the diagnostic accuracy of thyroid nodules. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428162</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:08 +0100</pubDate>
            <guid isPermaLink="false">5428162</guid>        </item>
        <item>
            <title>Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen‐deficient men</title>
            <link>http://www.medworm.com/index.php?rid=5428161&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04152.x</link>
            <description>Conclusions  These results indicate that once‐daily application of the testosterone topical solution 2% to the axillae is a safe and effective treatment for androgen replacement in hypogonadal men. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428161</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:06 +0100</pubDate>
            <guid isPermaLink="false">5428161</guid>        </item>
        <item>
            <title>High serum isoflavone concentrations are associated with the risk of precocious puberty in Korean girls</title>
            <link>http://www.medworm.com/index.php?rid=5428160&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04127.x</link>
            <description>Conclusion  These results suggest that elevated serum isoflavones may be associated with the risk of CPP in Korean girls. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428160</comments>
            <pubDate>Sun, 20 Nov 2011 10:55:04 +0100</pubDate>
            <guid isPermaLink="false">5428160</guid>        </item>
        <item>
            <title>Reduced levels of E‐cadherin correlate with progression of corticotroph pituitary tumours</title>
            <link>http://www.medworm.com/index.php?rid=5428159&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04109.x</link>
            <description>Conclusions  Corticotroph tumour progression was associated with reduced expression of the epithelial marker E‐cadherin. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428159</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:59 +0100</pubDate>
            <guid isPermaLink="false">5428159</guid>        </item>
        <item>
            <title>The increased incidence of congenital hypothyroidism: fact or fancy?</title>
            <link>http://www.medworm.com/index.php?rid=5428158&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04128.x</link>
            <description>Conclusion  The rising incidence of CH in Massachusetts is confined to mild and delayed cases. Our findings suggest that this rise is attributable to enhanced detection rather than an absolute increase in numbers. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428158</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:57 +0100</pubDate>
            <guid isPermaLink="false">5428158</guid>        </item>
        <item>
            <title>Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?</title>
            <link>http://www.medworm.com/index.php?rid=5428157&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04158.x</link>
            <description>Conclusions  I852M sequence variations represent genuine RET mutations, falling into ATA class A of weakly activating RET germline mutations. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428157</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:56 +0100</pubDate>
            <guid isPermaLink="false">5428157</guid>        </item>
        <item>
            <title>A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype</title>
            <link>http://www.medworm.com/index.php?rid=5428156&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04134.x</link>
            <description>Conclusions  Gene copy number analysis by MLPA should be considered in patients with negative conventional mutation screening. Although large MEN1 deletion causes MEN1, disruption of imprinted CDKN1C/p57KIP2 and IGF‐2 gene expression may contribute to tumour progression and aggressive phenotype. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428156</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:54 +0100</pubDate>
            <guid isPermaLink="false">5428156</guid>        </item>
        <item>
            <title>Subcutaneous adipose tissue thickness in adults – correlation with BMI and recommendations for pen needle lengths for subcutaneous self‐injection</title>
            <link>http://www.medworm.com/index.php?rid=5428155&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04132.x</link>
            <description>Conclusions  The data, with correlation between BMI and fat thickness at different injection sites in relation to gender, provide guidance in selecting an adequate pen needle length for deep and safe subcutaneous self‐injection. WHR was a much weaker predictor when compared to BMI. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428155</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:52 +0100</pubDate>
            <guid isPermaLink="false">5428155</guid>        </item>
        <item>
            <title>Haemoglobin A1c is associated with carotid intima–media thickness in a Chinese population</title>
            <link>http://www.medworm.com/index.php?rid=5428154&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04129.x</link>
            <description>Conclusions  Thus, HbA1c level is associated with subclinical atherosclerosis in carotid arteries in a Chinese population. The relationship is linear without an inflection point. However, HbA1c criterion is not a useful marker for the identification of subclinical atherosclerosis. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428154</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:51 +0100</pubDate>
            <guid isPermaLink="false">5428154</guid>        </item>
        <item>
            <title>Systematic review and meta‐analysis: islet autotransplantation after pancreatectomy for minimizing diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5428153&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04121.x</link>
            <description>Conclusions  IAT postpancreatectomy offers some patients a chance for insulin independence. Better data reporting are essential to establish the risks and benefits of IAT after pancreatic surgery. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428153</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:49 +0100</pubDate>
            <guid isPermaLink="false">5428153</guid>        </item>
        <item>
            <title>Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5428152&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04119.x</link>
            <description>Conclusions  Serum CXCL5 is an important determinant of carotid artery IMT in patients with type 2 diabetes. The correlation is independent of inflammation and glucose control. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428152</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:47 +0100</pubDate>
            <guid isPermaLink="false">5428152</guid>        </item>
        <item>
            <title>Activating mutations in the calcium‐sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia – a German survey</title>
            <link>http://www.medworm.com/index.php?rid=5428151&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04142.x</link>
            <description>Conclusion  This series increases the limited knowledge of mutations and phenotypes of this rare disorder. Mutation analysis of the CaSR gene facilitates patient and family management. Low dosages of calcitriol resulted in less frequent renal calcifications. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428151</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:46 +0100</pubDate>
            <guid isPermaLink="false">5428151</guid>        </item>
        <item>
            <title>High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21‐hydroxylase deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5428150&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04151.x</link>
            <description>Conclusion  In this unselected population of patients with classical 21OHD, we found high frequencies of adrenal tumours, particularly myelolipomas, and of hyperplasia and hypoplasia, and TART in SW. It is important that physicians are aware that benign adrenal and testicular tumours occur frequently in 21OHD. Furthermore, these findings may reflect inappropriate glucocorticoid therapy, making a case for the advancement of novel physiological treatment modalities. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428150</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:44 +0100</pubDate>
            <guid isPermaLink="false">5428150</guid>        </item>
        <item>
            <title>Salivary chromogranin A, but not α‐amylase, correlates with cardiovascular parameters during high‐intensity exercise</title>
            <link>http://www.medworm.com/index.php?rid=5428149&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04143.x</link>
            <description>Conclusions  These data suggest sCgA as a reliable marker of SAM activation. Furthermore, the relationship between sCgA and exercise intensity highlights the potential use of this noninvasive parameter in monitoring the adrenergic response during intense physical stress. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428149</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:42 +0100</pubDate>
            <guid isPermaLink="false">5428149</guid>        </item>
        <item>
            <title>How should hypomagnesaemia be investigated and treated?</title>
            <link>http://www.medworm.com/index.php?rid=5428148&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04092.x</link>
            <description>SummaryHypomagnesaemia is relatively common, with an estimated prevalence in the general population ranging from 2·5% to 15%. It may result from inadequate magnesium intake, increased gastrointestinal or renal loss or redistribution from extracellular to intracellular space. Drug‐induced hypomagnesaemia, particularly related to proton pump inhibitor (PPI) therapy, is being increasingly recognized. Most patients with hypomagnesaemia are asymptomatic; symptomatic magnesium depletion is often associated with multiple other biochemical abnormalities, including hypokalaemia, hypocalcaemia and metabolic acidosis. Manifestations of symptomatic hypomagnesaemia most often involve neuromuscular, cardiovascular and metabolic features. Patients with symptomatic hypomagnesaemia should be treated wit...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428148</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:41 +0100</pubDate>
            <guid isPermaLink="false">5428148</guid>        </item>
        <item>
            <title>Fine‐needle aspiration biopsy, ultrasound and BRAFv600E analysis – Is this the best FNAB combination for most patients?*</title>
            <link>http://www.medworm.com/index.php?rid=5428147&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04245.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428147</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:39 +0100</pubDate>
            <guid isPermaLink="false">5428147</guid>        </item>
        <item>
            <title>Serum myostatin in patients on maintenance haemodialysis: a useful biomarker of muscle wasting?*</title>
            <link>http://www.medworm.com/index.php?rid=5428146&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04225.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428146</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:37 +0100</pubDate>
            <guid isPermaLink="false">5428146</guid>        </item>
        <item>
            <title>Should ‘Mild Primary Hyperparathyroidism’ be reclassified as ‘insidious’: is it time to reconsider?</title>
            <link>http://www.medworm.com/index.php?rid=5428145&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04201.x</link>
            <description>SummaryPrimary hyperparathyroidism (PHPT) is a common incidental finding on routine biochemical testing, affecting around 1% of the population. The majority of individuals will be asymptomatic at diagnosis, with no evidence of end organ damage, and unless individuals aged &amp;lt;50 years at diagnosis, they are often considered to have ‘mild’ PHPT, as they do not meet published criteria for parathyroidectomy (PTX). However, there is increasing evidence that ‘mild’ PHPT is associated with adverse health outcomes. Long‐term observational studies describing the natural history of ‘mild’ PHPT suggest that even though biochemistry may be relatively stable in the majority, bone mineral density (BMD) does decline after approximately 10 years of observation, whereas significant impro...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428145</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:36 +0100</pubDate>
            <guid isPermaLink="false">5428145</guid>        </item>
        <item>
            <title>Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?</title>
            <link>http://www.medworm.com/index.php?rid=5428144&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04148.x</link>
            <description>This article will review the literature underpinning the hypothesis that spironolactone may have a role in maintaining muscle function in older people. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428144</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:34 +0100</pubDate>
            <guid isPermaLink="false">5428144</guid>        </item>
        <item>
            <title>Relationship between Monocyte/Macrophage Activation Marker Soluble CD163 and Insulin Resistance in Obese and Normal‐Weight Subjects</title>
            <link>http://www.medworm.com/index.php?rid=5428129&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04284.x</link>
            <description>Conclusions:  Monocyte/macrophage activation, as reflected by sCD163 levels, is strongly associated with HOMA‐IR in normal‐weight and obese subjects after controlling for known mediators of insulin resistance. Moreover, sCD163 adds to standard risk markers for predicting insulin resistance. These data suggest that monocyte/macrophage activation may be an important determinant of insulin resistance in obesity. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428129</comments>
            <pubDate>Sun, 20 Nov 2011 10:54:05 +0100</pubDate>
            <guid isPermaLink="false">5428129</guid>        </item>
        <item>
            <title>Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice</title>
            <link>http://www.medworm.com/index.php?rid=5428130&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04277.x</link>
            <description>Conclusion: Use of oral contraceptive pills containing ethinylestradiol should be avoided in women receiving treatment with growth hormone. Alternative options include oral or transdermal HRT preparations for those that require oestrogen replacement or a progesterone based regimen for contraceptive purposes. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428130</comments>
            <pubDate>Sat, 19 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428130</guid>        </item>
        <item>
            <title>Acute transient thyroid swelling after fine‐needle aspiration biopsy: three cases during only six weeks ‐ a rare complication?</title>
            <link>http://www.medworm.com/index.php?rid=5428131&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04294.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428131</comments>
            <pubDate>Fri, 18 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428131</guid>        </item>
        <item>
            <title>TSH‐Secreting Pituitary Carcinoma with Intrathecal Drop Metastases: A Case Report</title>
            <link>http://www.medworm.com/index.php?rid=5428136&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04288.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428136</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428136</guid>        </item>
        <item>
            <title>Endocrine Society Congenital Adrenal Hyperplasia Guidelines Great Content but how to deliver?</title>
            <link>http://www.medworm.com/index.php?rid=5428135&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04289.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428135</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428135</guid>        </item>
        <item>
            <title>Higher free thyroxine levels are associated with frailty in older men. The Health In Men Study</title>
            <link>http://www.medworm.com/index.php?rid=5428134&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04290.x</link>
            <description>Conclusions:  High‐normal FT4 level is an independent predictor of frailty among ageing men. This suggests that even within the euthyroid range, circulating thyroxine may contribute to reduced physical capability. Further studies are needed to clarify the utility of thyroid function testing and the feasibility of preventing or reversing frailty in older men. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428134</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428134</guid>        </item>
        <item>
            <title>Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF‐I Levels</title>
            <link>http://www.medworm.com/index.php?rid=5428133&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04291.x</link>
            <description>Conclusions:  This study demonstrates that in NAFLD patients the GHBP levels are increased and that the GH/IGF‐I axis is significantly altered probably leading to reduced IGF‐I bioavailability at tissue level. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428133</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428133</guid>        </item>
        <item>
            <title>Evaluation of thyroid nodules ‐ combined use of MIBI‐scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or non‐surgical therapy ‐ a retrospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5428132&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04292.x</link>
            <description>Conclusion:  Evaluation of cold thyroid nodules by MIBI‐scintigraphy aids therapeutic decisions: MIBI‐negative findings support non‐surgical management in about two thirds of patients, while MIBI‐positive findings have an increased risk of malignancy supporting surgical therapy. However the positive predictive value was low, which requires further research. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428132</comments>
            <pubDate>Fri, 11 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428132</guid>        </item>
        <item>
            <title>Impact of vitamin D‐related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions</title>
            <link>http://www.medworm.com/index.php?rid=5428143&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04285.x</link>
            <description>Conclusion:  For a given specificity, primary hyperparathyroidism diagnostic PTH thresholds were lower and sensitivities higher using ROC curves, derived from 25(OH)D replete versus deplete controls. The 25(OH)D status does not affect the efficiency of primary hyperparathyroidism diagnosis, using bivariate PTH/calcium reference density ellipses. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428143</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428143</guid>        </item>
        <item>
            <title>Intensity of pituitary adenoma on T2 weighted MRI predicts the response to octreotide treatment in newly diagnosed acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5428142&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04286.x</link>
            <description>Conclusion:  In patients with acromegaly, T2 signal intensity at diagnosis correlates with histological features and predicts biochemical outcome of first line SA treatment. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428142</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428142</guid>        </item>
        <item>
            <title>Extremes of an Aromatase Index Predict Increased 25‐year Risk of Cardiovascular Mortality in Older Women</title>
            <link>http://www.medworm.com/index.php?rid=5428141&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04287.x</link>
            <description>Conclusions:  These results suggest that aromatase is a novel endocrine factor predictive of CVD mortality among postmenopausal women. If confirmed, additional studies are needed to determine whether extremes of aromatase reflect genetic influences or underlying disease processes. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428141</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428141</guid>        </item>
        <item>
            <title>Identification and characterization of C106R, a novel mutation in the DNA‐binding domain of GCMB, in a family with autosomal dominant hypoparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5428140&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04256.x</link>
            <description>Conclusions:  We have identified a novel GCMB mutation that may explain AD‐HP in our family. However, the exact mechanism by which this heterozygous mutation leads to the disease in the described family remains to be elucidated. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428140</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428140</guid>        </item>
        <item>
            <title>The development of the Tuebingen Cushing’s disease quality of life inventory (Tuebingen CD‐25). Part II: normative data from 1784 healthy people</title>
            <link>http://www.medworm.com/index.php?rid=5428139&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04280.x</link>
            <description>Conclusion:  The Tuebingen CD‐25 is a feasible instrument to assess HRQoL in CD in a clinical and investigative setting and provides normative data for all age groups and genders. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428139</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428139</guid>        </item>
        <item>
            <title>Predicting the Onset of Addison’s Disease: ACTH, Renin, Cortisol, and 21‐hydroxylase Autoantibodies</title>
            <link>http://www.medworm.com/index.php?rid=5428138&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04276.x</link>
            <description>Conclusion:  Moderately elevated ACTH is a more useful early indicator of impending AD than 21OH‐AA, PRA, or peak cortisol, in the 2 months to 2 years preceding the onset of AD. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428138</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428138</guid>        </item>
        <item>
            <title>Fertility preservation in girls and young women</title>
            <link>http://www.medworm.com/index.php?rid=5428137&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04282.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428137</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5428137</guid>        </item>
        <item>
            <title>Fertility preservation</title>
            <link>http://www.medworm.com/index.php?rid=5383402&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04283.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383402</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383402</guid>        </item>
        <item>
            <title>A Phaeochromocytoma occurring in a patient with Parkinson’s disease on L‐dopa therapy: a diagnostic challenge</title>
            <link>http://www.medworm.com/index.php?rid=5383405&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04266.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383405</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383405</guid>        </item>
        <item>
            <title>Incidence and Implications of Negative Serum Thyroglobulin but Positive I‐131 Whole Body Scans in Patients With Well Differentiated Thyroid Cancer prepared with rhTSH or Thyroid Hormone Withdrawal</title>
            <link>http://www.medworm.com/index.php?rid=5383404&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04278.x</link>
            <description>Conclusions:  Our study confirms that in the setting of I‐131 ablation therapy or diagnostic I‐131 scanning, a significant proportion of patients (20.2% and 8.3% respectively) have residual benign or malignant thyroid tissue on whole body scanning despite a negative stimulated serum Tg level. Whether such patients who would otherwise be missed as having residual thyroid tissue on serum Tg testing alone have a worse clinical outcome remains uncertain. Our findings do however suggest performing both stimulated serum Tg/TgAb levels and I‐131 scans for follow up of patients with higher risk thyroid cancer may be important. There may also be a slightly higher incidence of this phenomenon in patients prepared with rhTSH rather than by thyroxine withdrawal. (Source: Clinical Endocrinology...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383404</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383404</guid>        </item>
        <item>
            <title>Diagnosis and Therapy for Cushing’s Disease with Negative Dynamic MRI finding: a single‐centre experience</title>
            <link>http://www.medworm.com/index.php?rid=5383403&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04279.x</link>
            <description>Conclusions:  Based on the findings outlined, MRI‐negative CD may be a surgically remediable syndrome, with a pathophysiological basis that primarily involves a pituitary cause of the hypercortisolaemia. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383403</comments>
            <pubDate>Wed, 02 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383403</guid>        </item>
        <item>
            <title>Impact of Moderate vs. Stringent TSH Suppression on Survival in Advanced Differentiated Thyroid Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5383401&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04272.x</link>
            <description>Conclusion: The care of patients with DTC and distant metastases is like walking an endocrinological tightrope: non‐suppressed TSH levels, i.e. &amp;gt; 0.1 mU/l, are associated with an impaired prognosis. There is, however, no prognostic benefit from suppressing TSH to levels lower than 0.1 mU/l. On the contrary, an improvement in prognosis might be achieved by keeping FT3 levels as low as possible. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5383401</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5383401</guid>        </item>
        <item>
            <title>Vitamin D: one size does not fit all</title>
            <link>http://www.medworm.com/index.php?rid=5363550&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04271.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5363550</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5363550</guid>        </item>
        <item>
            <title>Anterior Hypopituitarism is Rare and Autoimmune Disease is Common in Adults with Idiopathic Central Diabetes Insipidus</title>
            <link>http://www.medworm.com/index.php?rid=5348150&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04270.x</link>
            <description>Conclusions:  Our data suggest that anterior hypopituitarism is rare in adult idiopathic diabetes insipidus. Routine screening of these patients for anterior hypopituitarism may not therefore be indicated. The significant prevalence of autoimmune disease in this cohort supports the hypothesis that idiopathic diabetes insipidus may have an autoimmune aetiology. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5348150</comments>
            <pubDate>Wed, 26 Oct 2011 15:15:23 +0100</pubDate>
            <guid isPermaLink="false">5348150</guid>        </item>
        <item>
            <title>Maximising the accuracy of Inferior Petrosal Sinus Sampling: Validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5332768&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04257.x</link>
            <description>Conclusions:  Using Prolactin as a concurrent index of pituitary venous effluent helps us recognise whether pituitary venous blood has been accurately sampled. Normalising the IPS:peripheral ratios with Prolactin helps to improve the accuracy of the result and reduces the false negative rate. With regards to the usefulness / validity of this test in clinical practice; it is relevant, reproducible and is easily adaptable from the existing diagnostic sequence. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5332768</comments>
            <pubDate>Fri, 21 Oct 2011 03:20:06 +0100</pubDate>
            <guid isPermaLink="false">5332768</guid>        </item>
        <item>
            <title>The Consequences of GHRH‐R Haplo‐Insufficiency for Bone Quality and Insulin resistance</title>
            <link>http://www.medworm.com/index.php?rid=5317259&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04263.x</link>
            <description>Conclusions:  The present study suggests that one allele mutation in the GHRHR gene has a greater impact on energy metabolism than on bone quality. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317259</comments>
            <pubDate>Sat, 15 Oct 2011 18:35:06 +0100</pubDate>
            <guid isPermaLink="false">5317259</guid>        </item>
        <item>
            <title>The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a three year follow‐up</title>
            <link>http://www.medworm.com/index.php?rid=5302098&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04251.x</link>
            <description>Conclusions:  Coeliac disease, elevated TSH and TPOAb at presentation and a progressive increase of TSH are predictive factors for thyroid failure in HT patients. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5302098</comments>
            <pubDate>Mon, 10 Oct 2011 15:25:07 +0100</pubDate>
            <guid isPermaLink="false">5302098</guid>        </item>
        <item>
            <title>An objective scoring tool in the management of patients with pituitary apoplexy</title>
            <link>http://www.medworm.com/index.php?rid=5284246&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04081.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284246</comments>
            <pubDate>Wed, 05 Oct 2011 14:51:02 +0100</pubDate>
            <guid isPermaLink="false">5284246</guid>        </item>
        <item>
            <title>Response to letter: What medical options should be considered for the treatment of primary hyperparathyroidism?</title>
            <link>http://www.medworm.com/index.php?rid=5284245&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04101.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284245</comments>
            <pubDate>Wed, 05 Oct 2011 14:51:01 +0100</pubDate>
            <guid isPermaLink="false">5284245</guid>        </item>
        <item>
            <title>Management of primary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5284244&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04077.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284244</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:59 +0100</pubDate>
            <guid isPermaLink="false">5284244</guid>        </item>
        <item>
            <title>Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5284243&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04156.x</link>
            <description>Conclusions  This study identified underlying TSHR and TPO mutations in Korean patients with CH and revealed a possible relationship between imaging findings and mutation status. In addition, the low rate of mutation positivity suggests significant genetic heterogeneity of CH in the Korean population. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284243</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:57 +0100</pubDate>
            <guid isPermaLink="false">5284243</guid>        </item>
        <item>
            <title>Early detection of isolated left ventricular diastolic dysfunction in high‐risk differentiated thyroid carcinoma patients on TSH‐suppressive therapy</title>
            <link>http://www.medworm.com/index.php?rid=5284242&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04138.x</link>
            <description>Conclusions  In subjects with SCH at the early phase of TSH‐suppressive therapy, evidence of isolated longitudinal LV diastolic dysfunction was observed, despite a normal LV morphology. Further prospective studies to clarify the prognosis of picking‐up early diastolic dysfunction in asymptomatic patients are needed before serial measurements could be recommended. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284242</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:56 +0100</pubDate>
            <guid isPermaLink="false">5284242</guid>        </item>
        <item>
            <title>Hyperthyroidism and female urinary incontinence: a population‐based cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5284241&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04126.x</link>
            <description>Conclusion  Our results suggest an increased risk of UI in patients with hyperthyroidism at the 3‐year follow‐up. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284241</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:54 +0100</pubDate>
            <guid isPermaLink="false">5284241</guid>        </item>
        <item>
            <title>Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5284240&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04122.x</link>
            <description>Conclusions  In women with PCOS, the degree of anxiety, state and trait (STAI‐S, STAI‐T) appears to vary in a pattern similar to that of hyperandrogenemia and insulin resistance, independently of age and BMI. The pathophysiological mechanisms underlying the association of psychological morbidities with androgen excess and insulin resistance in PCOS remain to be elucidated. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284240</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:53 +0100</pubDate>
            <guid isPermaLink="false">5284240</guid>        </item>
        <item>
            <title>The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study</title>
            <link>http://www.medworm.com/index.php?rid=5284239&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04113.x</link>
            <description>Conclusions  Metabolic syndrome was no more frequent in a representative sample of PCOS Iranian population than in healthy controls. However, the prevalence of IR in PCOS appears to be higher than in controls. It seems that the association between PCOS and MetS needs more consideration. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284239</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:51 +0100</pubDate>
            <guid isPermaLink="false">5284239</guid>        </item>
        <item>
            <title>Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility</title>
            <link>http://www.medworm.com/index.php?rid=5284238&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04108.x</link>
            <description>Conclusions  In acromegalic patients, there is no difference in GH nadirs and test interpretation after the ingestion of 100 g or 75 g glucose. The OGTT75 is highly reproducible in men, but in women, it should be performed preferably in the early follicular phase. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284238</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:49 +0100</pubDate>
            <guid isPermaLink="false">5284238</guid>        </item>
        <item>
            <title>Comparison of primary octreotide‐lar and surgical treatment in newly diagnosed patients with acromegaly</title>
            <link>http://www.medworm.com/index.php?rid=5284237&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04106.x</link>
            <description>Conclusion  Primary surgical treatment seems to be slightly more effective than Oct‐LAR in terms of biochemical response and IGF‐1 control, besides tumour volume reduction, in patients with acromegaly with noninvasive tumours. Oct‐LAR is associated with more side effects such as cholelithiasis and glucose metabolism disorders and is more expensive. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284237</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:48 +0100</pubDate>
            <guid isPermaLink="false">5284237</guid>        </item>
        <item>
            <title>Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours</title>
            <link>http://www.medworm.com/index.php?rid=5284236&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04098.x</link>
            <description>Conclusions  3T MRI appears to offer increased conspicuity and detection of GH‐ and ACTH‐secreting pituitary microadenomas. It is potentially clinically useful when 1·5T imaging is negative or equivocal. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284236</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:46 +0100</pubDate>
            <guid isPermaLink="false">5284236</guid>        </item>
        <item>
            <title>Corticotrophin‐releasing hormone and desmopressin tests in the differential diagnosis between Cushing’s disease and pseudo‐Cushing state: a comparative study</title>
            <link>http://www.medworm.com/index.php?rid=5284235&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04096.x</link>
            <description>Conclusions  Our study indicates that the hCRH and DDAVP tests have similar diagnostic performance and present excellent agreement, without giving simultaneous misdiagnosis in any subject. Because of these characteristics, the use of both tests offers the physician a valuable tool for those cases of hypercortisolism which are difficult to interpret. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284235</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:44 +0100</pubDate>
            <guid isPermaLink="false">5284235</guid>        </item>
        <item>
            <title>Preterm birth and the endocrine regulation of growth in childhood and adolescence</title>
            <link>http://www.medworm.com/index.php?rid=5284234&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04116.x</link>
            <description>Conclusion  Preterm children are shorter and lighter than controls throughout childhood, remaining below their genetic height potential. Preterm birth appears to alter the endocrine regulation of postnatal growth in childhood and adolescence, so growth is no longer associated with its normal endocrine regulators. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284234</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:43 +0100</pubDate>
            <guid isPermaLink="false">5284234</guid>        </item>
        <item>
            <title>Different relationships between the first 2 years on growth hormone treatment and the d3‐growth hormone receptor polymorphism in short small‐for‐gestational‐age (SGA) children</title>
            <link>http://www.medworm.com/index.php?rid=5284233&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04104.x</link>
            <description>Conclusions  According to our results, the exon 3‐deleted GHR explains the better growth response to GH only for the first and not for the second year. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284233</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:41 +0100</pubDate>
            <guid isPermaLink="false">5284233</guid>        </item>
        <item>
            <title>Genotype of the LMNA 1908C&gt;T variant is associated with generalized obesity in Asian Indians in North India</title>
            <link>http://www.medworm.com/index.php?rid=5284232&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04111.x</link>
            <description>Conclusion LMNA 1908T/T and C/T genotypes emerged as independent genetic risk factors for generalized obesity in Asian north Indians. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284232</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:38 +0100</pubDate>
            <guid isPermaLink="false">5284232</guid>        </item>
        <item>
            <title>Wolfram syndrome in the Polish population: novel mutations and genotype–phenotype correlation</title>
            <link>http://www.medworm.com/index.php?rid=5284231&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04102.x</link>
            <description>Conclusions  Mean age of diagnosis of diabetes among the Polish patients was typical for Wolfram syndrome; however, compound‐heterozygous patients were slightly older at diabetes onset. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284231</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:36 +0100</pubDate>
            <guid isPermaLink="false">5284231</guid>        </item>
        <item>
            <title>Improving lipid profiles and increasing use of lipid‐lowering therapy in England: results from a national cross‐sectional survey – 2006</title>
            <link>http://www.medworm.com/index.php?rid=5284230&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04094.x</link>
            <description>Conclusions  Previously reported improvements in treatment and control rates between 1998 and 2003 continued between 2003 and 2006, with the biggest increases among those with established CVD and diabetes. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284230</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:33 +0100</pubDate>
            <guid isPermaLink="false">5284230</guid>        </item>
        <item>
            <title>Serum 25‐hydroxyvitamin D levels and the metabolic syndrome in older persons: a population‐based study</title>
            <link>http://www.medworm.com/index.php?rid=5284229&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04110.x</link>
            <description>Conclusions  Vitamin D deficiency is common in the older population in the Netherlands, and subjects with serum 25 OHD below 50 nm have a higher risk of the metabolic syndrome. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284229</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:30 +0100</pubDate>
            <guid isPermaLink="false">5284229</guid>        </item>
        <item>
            <title>Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5284228&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04130.x</link>
            <description>Conclusion  Patients in remission after pituitary surgery for CD showed a rapid decrease of adrenal responsiveness to exogenous ACTH stimulation. This phenomenon may be explained by ACTH‐receptor down‐regulation in the adrenal cortex after complete removal of the pituitary corticotroph adenoma. In our study, the postoperative low‐dose ACTH stimulation test had a sensitivity of 93% and a specificity of 87% in predicting immediate remission of CD after pituitary surgery. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284228</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:28 +0100</pubDate>
            <guid isPermaLink="false">5284228</guid>        </item>
        <item>
            <title>Overnight ACTH–cortisol dose responsiveness: comparison with 24‐h data, metyrapone administration and insulin‐tolerance test in healthy adults</title>
            <link>http://www.medworm.com/index.php?rid=5284227&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04125.x</link>
            <description>Conclusions  The results suggest that endogenous ACTH–adrenal drive can be approximated from overnight 8‐h sampling of paired ACTH and cortisol concentrations. This strategy may have merit in clinical research in childhood, pregnancy, anxiety states and frail elderly individuals, when ACTH injections are not desired. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284227</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:27 +0100</pubDate>
            <guid isPermaLink="false">5284227</guid>        </item>
        <item>
            <title>What medical options should be considered for the treatment of primary hyperparathyroidism?</title>
            <link>http://www.medworm.com/index.php?rid=5284226&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04050.x</link>
            <description>SummaryPrimary hyperparathyroidism (PHPT) is a common, often asymptomatic, endocrine disorder characterized by hypercalcaemia in the face of a nonsuppressed parathyroid hormone (PTH) level. For those with symptomatic disease or who meet surgical criteria, parathyroidectomy is the treatment of choice. However, those patients who do not meet surgical criteria or who cannot undergo or refuse surgery must be managed medically. Medical management of PHPT involves continual assessment to determine who will benefit from surgical intervention, replacement of vitamin D, treatment of parathyroid bone disease and management of hypercalcaemia and renal stone disease. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284226</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:25 +0100</pubDate>
            <guid isPermaLink="false">5284226</guid>        </item>
        <item>
            <title>Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5284225&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04214.x</link>
            <description>SummaryMitotane [1‐(2‐chlorophenyl)‐1‐(4‐chlorophenyl)‐2,2‐dichloroethane, (o,p’‐DDD)] is the only drug approved for the treatment for adrenocortical carcinoma (ACC) and has also been used for various forms of glucocorticoid excess. Through still largely unknown mechanisms, mitotane inhibits adrenal steroid synthesis and adrenocortical cell proliferation. Mitotane increases hepatic metabolism of cortisol, and an increased replacement dose of glucocorticoids is standard of care during mitotane treatment. Recently, sunitinib, a multityrosine kinase inhibitor (TKI), has been found to be rapidly metabolized by CYP3A4 during mitotane treatment, indicating clinically relevant drug interactions with mitotane. We here summarize the current evidence concerning mitotane‐induced c...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284225</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:23 +0100</pubDate>
            <guid isPermaLink="false">5284225</guid>        </item>
        <item>
            <title>Vitamin D, cardiovascular disease and mortality</title>
            <link>http://www.medworm.com/index.php?rid=5284224&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04147.x</link>
            <description>SummaryA poor vitamin D status, i.e. low serum levels of 25‐hydroxyvitamin D [25(OH)D], is common in the general population. This finding is of concern not only because of the classic vitamin D effects on musculoskeletal outcomes, but also because expression of the vitamin D receptor (VDR) and vitamin D metabolizing enzymes in the heart and blood vessels suggests a role of vitamin D in the cardiovascular system. VDR‐knockout mice suffer from cardiovascular disease (CVD), and various experimental studies suggest cardiovascular protection by vitamin D, including antiatherosclerotic, anti‐inflammatory and direct cardio‐protective actions, beneficial effects on classic cardiovascular risk factors as well as suppression of parathyroid hormone (PTH) levels. In epidemiological studies, lo...</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284224</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:22 +0100</pubDate>
            <guid isPermaLink="false">5284224</guid>        </item>
        <item>
            <title>Twenty‐four hour profiles of plasma glucose, insulin, C‐peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short‐term medium‐dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action</title>
            <link>http://www.medworm.com/index.php?rid=5284222&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04242.x</link>
            <description>Conclusion:  Short‐term medium‐dose prednisone treatment induces postprandial hyperglycaemia in T2DM and AR predominantly from midday to midnight due suppression of insulin secretion followed by decreased insulin action that dissipates overnight. Effective treatment of prednisone‐induced hyperglycaemia should target both rapid onset relative insulin deficiency and a less than 24‐hour total duration of effect. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284222</comments>
            <pubDate>Wed, 05 Oct 2011 14:50:19 +0100</pubDate>
            <guid isPermaLink="false">5284222</guid>        </item>
        <item>
            <title>ACTH‐Induced Cortisol Release Is Related to the Copy Number of the C4B Gene Encoding the Fourth Component of Complement in Patients with Non‐functional Adrenal Incidentaloma</title>
            <link>http://www.medworm.com/index.php?rid=5284223&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04247.x</link>
            <description>Conclusions:  The C4B*Q0 genotype may be associated with hyperreactivity of the HPA axis (manifested as an increased responsiveness to ACTH‐stimulation), probably through enhanced function of steroid 21‐hydroxylase. Since hyperreactivity of the HPA axis is known to be associated with an increased risk of cardiovascular disease, our present findings may explain the increased cardiovascular morbidity and mortality of C4B*Q0 carriers. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284223</comments>
            <pubDate>Mon, 03 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284223</guid>        </item>
        <item>
            <title>The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5268611&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04244.x</link>
            <description>Conclusions:  Circulating lipid‐related intermediate metabolites can be closely associated with inflammation, oxidative stress, and arterial stiffness in early diabetes. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5268611</comments>
            <pubDate>Fri, 30 Sep 2011 11:10:32 +0100</pubDate>
            <guid isPermaLink="false">5268611</guid>        </item>
        <item>
            <title>Increases in muscle blood flow after a mixed meal are impaired at all stages of type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5249668&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04211.x</link>
            <description>Conclusions:  These results suggest that increase of muscle blood flow after a meal is impaired at all stages of type‐2 diabetes. This defect influences glucose uptake, and is associated with impaired lipid metabolism in the postprandial state. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5249668</comments>
            <pubDate>Sat, 24 Sep 2011 22:24:07 +0100</pubDate>
            <guid isPermaLink="false">5249668</guid>        </item>
        <item>
            <title>Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk</title>
            <link>http://www.medworm.com/index.php?rid=5235159&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04216.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5235159</comments>
            <pubDate>Tue, 20 Sep 2011 17:24:08 +0100</pubDate>
            <guid isPermaLink="false">5235159</guid>        </item>
        <item>
            <title>Author’s response*</title>
            <link>http://www.medworm.com/index.php?rid=5221681&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04071.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221681</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:17 +0100</pubDate>
            <guid isPermaLink="false">5221681</guid>        </item>
        <item>
            <title>Acute transient thyroid swelling after fine‐needle aspiration biopsy: rare complication of unknown origin</title>
            <link>http://www.medworm.com/index.php?rid=5221680&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04064.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221680</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:13 +0100</pubDate>
            <guid isPermaLink="false">5221680</guid>        </item>
        <item>
            <title>When is a phaeo not a phaeo? Depression in an adolescent leading to a phaeochromocytoma‐like biochemical profile</title>
            <link>http://www.medworm.com/index.php?rid=5221679&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04063.x</link>
            <description>(Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221679</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:12 +0100</pubDate>
            <guid isPermaLink="false">5221679</guid>        </item>
        <item>
            <title>The association of serum prolactin concentration with inflammatory biomarkers – cross‐sectional findings from the population‐based Study of Health in Pomerania</title>
            <link>http://www.medworm.com/index.php?rid=5221678&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04075.x</link>
            <description>Conclusions  Serum PRL concentrations are associated with inflammatory biomarkers including IL‐6 and WBC, but not hsCRP or fibrinogen. The suggested role of PRL in inflammation needs further investigation in future prospective studies. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221678</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:10 +0100</pubDate>
            <guid isPermaLink="false">5221678</guid>        </item>
        <item>
            <title>Pyrosequencing cut‐off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules</title>
            <link>http://www.medworm.com/index.php?rid=5221677&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04115.x</link>
            <description>Conclusions  Pyrosequencing is an effective method for detecting the BRAFV600E mutation in FNAB samples. By allowing the optimal cut‐off value to be determined, pyrosequencing improves the diagnostic sensitivity while eliminating the possibility of FP results. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221677</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:08 +0100</pubDate>
            <guid isPermaLink="false">5221677</guid>        </item>
        <item>
            <title>Health‐related quality of life among thyroid cancer survivors: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5221676&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04114.x</link>
            <description>Conclusion  This review indicates that thyroid cancer survivors generally have a similar or slightly worse HRQoL compared with the normative population; however, they report some specific medical problems after cancer treatment and follow‐up tests, which have a direct negative impact on their current HRQoL and could affect their long‐term HRQoL. Specific longitudinal survivorship studies are lacking. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221676</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:07 +0100</pubDate>
            <guid isPermaLink="false">5221676</guid>        </item>
        <item>
            <title>A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon‐induced thyroiditis</title>
            <link>http://www.medworm.com/index.php?rid=5221675&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04112.x</link>
            <description>Conclusions  Our results point to the immunomodulatory effects of IFN‐α on different lymphocyte subpopulations and a possible role of Th1 response and Tregs in patients with HCV who developed IIT. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221675</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:05 +0100</pubDate>
            <guid isPermaLink="false">5221675</guid>        </item>
        <item>
            <title>Thyroid incidentaloma identified by 18F‐fluorodeoxyglucose positron emission tomography with CT (FDG‐PET/CT): clinical and pathological relevance</title>
            <link>http://www.medworm.com/index.php?rid=5221674&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04107.x</link>
            <description>Conclusions  The presence of focal uptake with high SUV max and euthyroidism correlate with high likelihood of malignancy. Performing a neck US would have to be recommended in all patients with euthyroidism and an incidental FDG‐PET/CT focal thyroid uptake. We do not suggest to use FDG‐PET/CT as a screening tool for thyroid cancer in the general population, because of both its high cost and low incidence of thyroid incidentaloma at FDG‐PET/CT. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221674</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:03 +0100</pubDate>
            <guid isPermaLink="false">5221674</guid>        </item>
        <item>
            <title>Long‐term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5221673&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04093.x</link>
            <description>Conclusions  Treatment with metformin is indicated in all hyperinsulinaemic overweight patients with PCOS, especially in those with NAFLD. These data appear even more interesting considering their increased risk to develop metabolic and hepatic complications. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221673</comments>
            <pubDate>Fri, 16 Sep 2011 01:01:01 +0100</pubDate>
            <guid isPermaLink="false">5221673</guid>        </item>
        <item>
            <title>Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers</title>
            <link>http://www.medworm.com/index.php?rid=5221672&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04084.x</link>
            <description>Conclusion  Plasma FGF21 follows a circadian rhythm during a 72‐h fast in healthy female subjects. The circadian regulation has a stronger impact on plasma FGF21 than the fasting status over 72‐h period. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221672</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:59 +0100</pubDate>
            <guid isPermaLink="false">5221672</guid>        </item>
        <item>
            <title>Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin‐deficient hypopituitary male patients</title>
            <link>http://www.medworm.com/index.php?rid=5221671&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04074.x</link>
            <description>Conclusions  The lower dose of hydrocortisone (10 mg/5 mg) produces a more physiological cortisol profile, without compromising QoL, compared to higher doses still used in clinical practice. This may have important implications in these patients, known to have excess cardiovascular mortality. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221671</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:57 +0100</pubDate>
            <guid isPermaLink="false">5221671</guid>        </item>
        <item>
            <title>Pituitary apoplexy in non‐functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences</title>
            <link>http://www.medworm.com/index.php?rid=5221670&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04068.x</link>
            <description>Conclusions  Patients with classical pituitary apoplexy may show recurrent pituitary tumour growth and therefore these patients need continued post‐operative surveillance if they have not had post‐operative radiotherapy. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221670</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:56 +0100</pubDate>
            <guid isPermaLink="false">5221670</guid>        </item>
        <item>
            <title>Aortic root ectasia in patients with acromegaly: experience at a single center</title>
            <link>http://www.medworm.com/index.php?rid=5221669&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04067.x</link>
            <description>Conclusion  The aortic root diameter was higher, and the prevalence of aortic ectasia was more common in acromegalic patients than in controls. In addition, only acromegalic disease was associated with aortic ectasia, suggesting the direct effects of GH and insulin‐like growth factor‐I excess on the cardiovascular system. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221669</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:54 +0100</pubDate>
            <guid isPermaLink="false">5221669</guid>        </item>
        <item>
            <title>Quantifying the risk of hypoglycaemia in children undergoing the glucagon stimulation test</title>
            <link>http://www.medworm.com/index.php?rid=5221668&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04117.x</link>
            <description>Conclusions  Hypoglycaemia is not uncommon during the low‐dose GST. Young children, especially those &amp;lt;8 years old, are particularly at risk. BG monitoring should be considered essential from a safety perspective. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221668</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:52 +0100</pubDate>
            <guid isPermaLink="false">5221668</guid>        </item>
        <item>
            <title>Growth hormone is positively associated with surrogate markers of bone turnover during puberty</title>
            <link>http://www.medworm.com/index.php?rid=5221667&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04088.x</link>
            <description>Conclusion  GH is strongly associated with pubertal bone metabolism, independent of systemic IGF‐1 in girls and boys. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221667</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:50 +0100</pubDate>
            <guid isPermaLink="false">5221667</guid>        </item>
        <item>
            <title>Identifying metabolically obese but normal‐weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study</title>
            <link>http://www.medworm.com/index.php?rid=5221666&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04085.x</link>
            <description>Conclusions  More than 10% of normal‐weight subjects were classed as MONW in this cohort. Identification of these subjects based on lipid profiles could aid in the early detection of a high risk group of developing cardiometabolic diseases. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221666</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:48 +0100</pubDate>
            <guid isPermaLink="false">5221666</guid>        </item>
        <item>
            <title>Association of AGER gene G82S polymorphism with the severity of coronary artery disease in Chinese Han population</title>
            <link>http://www.medworm.com/index.php?rid=5221665&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04079.x</link>
            <description>Conclusions  AGER 82S allele showed a protective effect on CAD severity in the presence of T2DM in Chinese Han population. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221665</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:46 +0100</pubDate>
            <guid isPermaLink="false">5221665</guid>        </item>
        <item>
            <title>Effects of a three‐month combined exercise programme on fibroblast growth factor 21 and fetuin‐A levels and arterial stiffness in obese women</title>
            <link>http://www.medworm.com/index.php?rid=5221664&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04078.x</link>
            <description>Conclusions  A 3‐month combined exercise programme decreases the FGF21 levels as well as arterial stiffness in obese Korean women. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221664</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:44 +0100</pubDate>
            <guid isPermaLink="false">5221664</guid>        </item>
        <item>
            <title>Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids</title>
            <link>http://www.medworm.com/index.php?rid=5221663&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04073.x</link>
            <description>Conclusion  Restoring serum DHEAS levels in older adults to young adult levels for 1 year does not appear to reduce central adiposity or improve insulin action. The benefit of DHEA on decreasing serum triglycerides must be weighed against the HDL‐lowering effect. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221663</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:42 +0100</pubDate>
            <guid isPermaLink="false">5221663</guid>        </item>
        <item>
            <title>Serum fetuin‐A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5221662&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04070.x</link>
            <description>Conclusions  IGT and NDD are positively associated with serum fetuin‐A concentrations in subjects without NAFLD independent of cardiometabolic risk factors. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221662</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:40 +0100</pubDate>
            <guid isPermaLink="false">5221662</guid>        </item>
        <item>
            <title>Mortality and morbidity in Cushing’s syndrome in New Zealand</title>
            <link>http://www.medworm.com/index.php?rid=5221661&amp;cid=s_33008_15_f&amp;fid=33008&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2265.2011.04124.x</link>
            <description>Conclusion  CS is associated with both high mortality and a high prevalence of co‐morbidities, even when biochemical cure rates are between 80% and 90%. (Source: Clinical Endocrinology)</description>
            <author>Clinical Endocrinology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221661</comments>
            <pubDate>Fri, 16 Sep 2011 01:00:36 +0100</pubDate>
            <guid isPermaLink="false">5221661</guid>        </item>
    </channel>
</rss>

